PRRT
¹⁷⁷Lu-DOTATATE therapy for neuroendocrine tumours.
Radionuclide Therapy & Theranostics
Theranostics & Radionuclide Therapy.
See it. Target it. Treat it precisely.
PRRT, PSMA therapy, FAPI therapy, radioiodine therapy and dosimetry, planned around what your scan shows.
With Dr. Noaline Sinha, Nuclear Medicine & Radiotheranostics.
Artemis Hospital, Sector 51, Gurugram
Understanding theranostics
One target.Two steps.
Theranostics uses the same molecular target for both diagnosis and treatment. A scan shows whether a disease carries the target, and a matched radionuclide therapy then acts on it. Treatment is planned around your own scan findings.
Diagnose: see the target
A PET-CT scan shows whether the disease carries the target the therapy is designed to act on.
Treat: act on the target
A matched radionuclide therapy delivers treatment directly to the diseased tissue, and dosimetry can be used to review it.
Your doctor will advise whether theranostics is appropriate for you.
Have a question?
Share your details and our team will get in touch.
Focus areas
Targeted therapy for selected conditions.
Suitability is decided after your reports and scans are reviewed.
PSMA therapy
¹⁷⁷Lu-PSMA and ²²⁵Ac-PSMA targeted therapy for prostate cancer.
FAPI therapy
¹⁷⁷Lu-FAPI targeted radionuclide therapy.
Radioiodine therapy
¹³¹I for hyperthyroidism and differentiated thyroid carcinoma.
Dosimetry
Quantitative SPECT-CT to individualise and review therapy.
Scope of Services
Therapies and planning offered.
From pre-therapy evaluation to dosimetry and follow-up.
Radioiodine Therapy
2 therapies
- ¹³¹I Therapy for Hyperthyroidism
- ¹³¹I Therapy for Differentiated Thyroid Carcinoma
Peptide Receptor Radionuclide Therapy (PRRT)
1 therapy
- ¹⁷⁷Lu-DOTATATE Therapy for Neuroendocrine Tumours
Prostate Cancer Theranostics
2 therapies
- ¹⁷⁷Lu-PSMA Targeted Radionuclide Therapy
- ²²⁵Ac-PSMA Targeted Alpha Therapy
Other Targeted Radionuclide Therapies
6 therapies
- ¹⁷⁷Lu-FAPI Targeted Radionuclide Therapy
- ¹³¹I-MIBG Therapy
- Transarterial Radioembolisation (TARE) for Liver Tumours
- Radionuclide Therapy for Bone Pain Palliation (⁸⁹Sr / ¹⁵³Sm)
- Radiosynovectomy (⁹⁰Y Colloid)
- Other Targeted Radionuclide Therapies under Approved Institutional Protocols
Therapy Planning, Imaging & Dosimetry
5 therapies
- Pre-Therapy Patient Evaluation and Treatment Planning
- Post-Therapy Imaging and Response Assessment
- ¹⁷⁷Lu-PSMA and ¹⁷⁷Lu-DOTATATE Post-Therapy Imaging
- Quantitative SPECT-CT-Based Radionuclide Therapy Dosimetry
- Longitudinal Follow-Up and Multidisciplinary Treatment Coordination
Investigations and therapies are offered based on individual clinical indications, patient suitability and applicable regulatory guidelines.
Your Visit, Step by Step
Know what to expect. Feel more prepared.
How treatment is planned, given and followed up.
- 01
Evaluation
Your reports and scans are reviewed with your treating team.
- 02
Diagnostic scan
A scan shows whether targeted therapy is suitable for you.
- 03
Planning & therapy
Treatment is planned around your scan, then given under supervision.
- 04
Follow-up
Post-therapy imaging and tests review your response.
The exact process depends on your condition and the therapy planned.
Before Your Visit
A little preparation.A smoother experience.
What to discuss with the team
Your reports & previous scans
Keep relevant records available.
Medicines
Tell the team about the medicines you take.
Pregnancy & breastfeeding
Let the team know before your appointment.
Radiation safety
You and your family will be told what precautions apply, and for how long.
Radiation safety at home
After therapy you will be given written precautions for you and your family. Contact the team if you are unsure about any of them.
For Referring Clinicians
Referring a patient for radionuclide therapy.
A short guide for referring doctors.
- 1
Pre-therapy evaluation
Each patient is evaluated before treatment, including review of reports and diagnostic imaging, to confirm suitability and plan therapy.
- 2
Therapies available
Radioiodine (¹³¹I) therapy, ¹⁷⁷Lu-DOTATATE PRRT, ¹⁷⁷Lu-PSMA and ²²⁵Ac-PSMA therapy, ¹⁷⁷Lu-FAPI, ¹³¹I-MIBG, TARE, bone-pain palliation and radiosynovectomy, under applicable regulatory guidelines and institutional protocols.
- 3
Dosimetry and response
Post-therapy imaging and quantitative SPECT-CT dosimetry support individualised treatment and response assessment.
- 4
Coordination
Longitudinal follow-up and multidisciplinary coordination with the referring and treating team.
Questions before you refer? Contact Dr. Sinha directly.
Your consultant
ConsultDr. Noaline Sinha.
Chairperson of the Department of Nuclear Medicine & Radiotheranostics, with over 25 years in molecular imaging and radionuclide therapy.
Experience
Over 25 years in nuclear medicine, leading the Department of Nuclear Medicine & Radiotheranostics.
Radiation safety
Certified Radiation Safety Officer (RSO-II) by the Atomic Energy Regulatory Board.
Collaborative practice
Works alongside referring and treating clinicians on every case.
Dr. Noaline Sinha
Chairperson, Nuclear Medicine & Radiotheranostics
FAQs
A little claritybefore your treatment.
Common questions about theranostics and radionuclide therapy.
Still have questions?Speak to our team for guidance before your visit.
Theranostics pairs diagnostic imaging with targeted radionuclide therapy using the same molecular target, so treatment is planned around what the scan shows.
It is considered for selected conditions, such as neuroendocrine tumours, prostate cancer and thyroid disease, where a scan shows the disease can be treated through the same target. Your doctor will advise whether it suits you.
Dosimetry uses quantitative imaging after therapy to estimate how much radiation reaches the disease and normal organs, helping to individualise and review treatment.
Yes. You will be given clear written instructions on precautions for you and your family after treatment.
This depends on the therapy. The team will tell you in advance whether any stay is needed.
Request an Appointment
Fill in your details and our team will get back to you to confirm your appointment.
Take the Next Step
Let’s Begin Your Journey to Better Care.
Reach out to schedule a personalised consultation or speak with our team. We’re here to guide you with clarity, compassion, and expert care — every step of the way.
Book a Consultation
Schedule a personalised consultation with Dr. Noaline Sinha at your convenience.
Talk to Our Team
Have questions? Our care team is here to help you with guidance and information.
Consult in Gurugram
Consultations are held in person in Gurugram. The team will confirm the details with you.